Use of drug treatment for secondary prevention of cardiovascular disease in urban and rural communities of China: China Kadoorie Biobank Study of 0.5 million people
Yiping Chen,Liming Li,Liming Li,Qiuli Zhang,Robert Clarke,Junshi Chen,Yu Guo,Zheng Bian,Xianhai Pan,Richard Peto,Ran Tao,Kunxiang Shi,Rory Collins,Liangcai Ma,Huarong Sun,Zhengming Chen +15 more
Reads0
Chats0
TLDR
Only one in three individuals with prior CVD was routinely treated with any proven secondary preventive drugs, and the treatment rates were correlated with the existence of other risk factors, in particular evidence of hypertension.About:
This article is published in International Journal of Cardiology.The article was published on 2014-03-01 and is currently open access. It has received 48 citations till now. The article focuses on the topics: Biobank.read more
Citations
More filters
Journal ArticleDOI
Stroke in China: advances and challenges in epidemiology, prevention, and management
Simiao Wu,Bo Wu,Ming Liu,Zhengming Chen,Wenzhi Wang,Craig S. Anderson,Peter Sandercock,Yongjun Wang,Yining Huang,L Cui,C Pu,Jianping Jia,T Zhang,Xinfeng Liu,S Zhang,Peng Xie,Dongsheng Fan,Xunming Ji,Wong K-Sl.,L Wang +19 more
TL;DR: Future efforts should focus on providing more balanced availability of specialised stroke services across the country, enhancing evidence-based practice, and encouraging greater translational research to improve outcome of patients with stroke.
Journal ArticleDOI
Outdoor temperature, blood pressure, and cardiovascular disease mortality among 23 000 individuals with diagnosed cardiovascular diseases from China.
Ling Yang,Liming Li,Sarah Lewington,Yu Guo,Paul Sherliker,Zheng Bian,Rory Collins,Richard Peto,Yun Liu,Rong Yang,Yongrui Zhang,Guangchun Li,Shumei Liu,Zhengming Chen +13 more
TL;DR: Careful monitoring and more aggressive blood pressure lowering treatment in the cold months are needed to help reduce the winter excess CVD mortality in high-risk individuals.
Journal ArticleDOI
Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults
Yiping Chen,Neil Wright,Yu Guo,Iain Turnbull,Christiana Kartsonaki,Christiana Kartsonaki,Ling Yang,Ling Yang,Zheng Bian,Pei Pei,D Pan,Y Zhang,Haiqiang Qin,Yongjun Wang,Jun Lv,Ming Liu,Z Hao,Canqing Yu,Richard Peto,Rory Collins,Liming Li,Robert Clarke,Zhengming Chen,Zhengming Chen +23 more
TL;DR: After a first stroke, the risk of recurrence or death within 5 years was high among this population of Chinese adults, and urgent improvements to secondary prevention of stroke in China are needed to reduce these risks.
Journal Article
Functional foods and their role in cancer prevention and health promotion: a comprehensive review.
Mohammad Aghajanpour,Mohamad Reza Nazer,Zia Obeidavi,Mohsen Akbari,Parya Ezati,Nasroallah Moradi Kor +5 more
TL;DR: The evaluation of cancer will indicate where cancer treatment is ineffective and wasteful, and offer alternative cancer care packages that are cost-effective and suited to low-resource settings.
Journal ArticleDOI
Blood cholesterol in late-life and cognitive decline: a longitudinal study of the Chinese elderly
TL;DR: Wang et al. as discussed by the authors examined whether higher blood cholesterol concentrations were associated with faster cognitive decline in a community-based longitudinal study of Chinese elderly and found that higher baseline TC and LDL-C concentrations were significantly associated with greater cognitive decline.
References
More filters
Journal ArticleDOI
Effects of an angiotensin-converting -enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
TL;DR: Ramipril significantly reduces the rates of death, myocardial infarction, and stroke in a broad range of high-risk patients who are not known to have a low ejection fraction or heart failure.
Journal ArticleDOI
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
Colin Baigent,L Blackwell,Jonathan Emberson,Lisa Holland,Christina Reith,Neeraj Bhala,Richard Peto,Elizabeth H Barnes,Anthony C Keech,John Simes,Rory Collins +10 more
TL;DR: Further reductions in LDL cholesterol safely produce definite further reductions in the incidence of heart attack, of revascularisation, and of ischaemic stroke, with each 1·0 mmol/L reduction reducing the annual rate of these major vascular events by just over a fifth.
Journal ArticleDOI
Beta blockade during and after myocardial infarction: an overview of the randomized trials
TL;DR: The aim has been not only to review the 65-odd randomized beta blocker trials but also to demonstrate that when many randomized trials have all applied one general approach to treatment, it is often not appropriate to base inference on individual trial results.
Journal ArticleDOI
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
Stephen MacMahon,Bruce Neal,Christophe Tzourio,Anthony Rodgers,Mark Woodward,J. Cutler,Craig S. Anderson,John Chalmers,T. Ohkubo,M. G. Bouser,Stephen M. Davis,Geoffrey A. Donnan,L. Hansson,Stephen B. Harrap,K. R. Lees,L. Liu,G. Mancia,T. Omae,J. Reid,R. Sega,A. Terent,C. Warlow,N. Anderson,C. Bladin,B.C. Chambers,G. Gordon,N. Sharpe,Rory Collins,Peter Sandercock,John Simes,P. Sleight,A. Brnabic,S. Colman,L. Francis,A. Lee,L. Gong,M.-G. Bousser,T. Yamaguchi,F. William,Q. Deng,D. X. Hu,William Y.S. Wang,A. L. Wu,L. Y. Ma,Z. Y. Tao,V. Biousse,Karine Berthet,L. Ben Slamia,C. Le Denmat,S. Crespi,G. Foglia,C. Fujimoto,S. Matsumura,K. Marttala,M. Pettersson,M. Safwenberg,J. Fenton,Y. McIlvenna,R. Currie,H. Bartram,J. Briad,A. Clague,Y. Cleverly,M. Cosson,A. Culpan,D. Douglas,S. Flett,B. Gray,T. Holloway,A. Milne,R. Prasad,Y. Ratnasabapathy,A. Santos,M. Wills,T. Agnew,Neil Chapman,N. Lewis,B. Mullane +77 more
TL;DR: This blood-pressure-lowering regimen reduced the risk of stroke among both hypertensive and non-hypertensive individuals with a history of stroke or transient ischaemic attack, irrespective of their blood pressure.
Journal ArticleDOI
Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
Earl S. Ford,Umed A. Ajani,Janet B. Croft,Julia A Critchley,Darwin R. Labarthe,Thomas E. Kottke,Wayne H. Giles,Simon Capewell +7 more
TL;DR: In this paper, the authors applied a previously validated statistical model, Impact, to data on the use and effectiveness of specific cardiac treatments and on changes in risk factors between 1980 and 2000 among U.S. adults 25 to 84 years old.
Related Papers (5)
Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey
Salim Yusuf,Shofiqul Islam,Clara K Chow,Sumathy Rangarajan,Gilles R. Dagenais,Rafael Diaz,Rajeev Gupta,Roya Kelishadi,Romaina Iqbal,Alvaro Avezum,Annamarie Kruger,Raman Kutty,Fernando Lanas,Liu Lisheng,Li Wei,Patricio Lopez-Jaramillo,Aytekin Oguz,Omar Rahman,H Swidan,Khalid Yusoff,Witold Zatonski,Annika Rosengren,Koon K. Teo +22 more
Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013.
Maigeng Zhou,Haidong Wang,Jun Zhu,Wanqing Chen,Linhong Wang,Shiwei Liu,Yichong Li,Lijun Wang,Yunning Liu,Peng Yin,Jiangmei Liu,Shicheng Yu,Feng Tan,Ryan M Barber,Matthew M Coates,Daniel Dicker,Maya S Fraser,Diego Gonzalez-Medina,Hannah Hamavid,Yuantao Hao,Guoqing Hu,Guohong Jiang,Haidong Kan,Alan D. Lopez,Michael R. Phillips,Michael R. Phillips,Jun She,Theo Vos,Xia Wan,Gelin Xu,Lijing L. Yan,Chuanhua Yu,Yong Zhao,Yingfeng Zheng,Xiaonong Zou,Mohsen Naghavi,Yu Wang,Christopher J L Murray,Gonghuan Yang,Xiaofeng Liang +39 more